Last summer, almost to the day, I fractured and dislocated my knee. Let’s just say it wasn’t pleasant. I was playing (soccer/football) and the tackle was “reckless and ridiculous.” Here’s my post from a year ago. So, on the anniversary of the tackle and an injury that sent my life in new directions, here are […]Read more "Fracture: The Paper Anniversary"
Originally posted on Points: The Blog of the Alcohol & Drugs History Society:
Editor’s Note: This is the last post in our series from the Cannabis: Global Histories conference, held at the University of Strathclyde from April 19-20, 2018. It comes from Lucia Romero, an assistant researcher at CONICET (Argentina’s National Scientific and Technical Research…
“Right to Try” (Again): A history of the experimental therapy movement BY LUCAS RICHERT APRIL 16, 2018 CULTURE, HISTORY, POLITICS, RESEARCH In recent weeks and months, momentum has increased on Capitol Hill to craft “right to try” laws that would profoundly change the medical landscape. The national legislation will allow terminally ill patients more access to experimental therapies […]Read more "The Right to Try"
The ADHS is pleased to announce that the editorship of its journal, *The Social History of Alcohol and Drugs*, will be taken over by Prof. Nancy D. Campbell (Rensselaer Polytechnic Institute), Prof. David Herzberg (Buffalo) and Dr. Lucas Richert (Strathclyde). The society would also like to express its gratitude for the work that outgoing editor, […] […]Read more "New Editors at Social History of Alcohol and Drugs"
The ADHS is excited to announce that its next bi-annual conference will be held between 12 and 15 June 2019, at the David F. Musto Center for Drug Policy Studies, Shanghai University, China. The conference will be organised by Prof. Jim Mills, of the University of Strathclyde and Prof. Yong-an Zhang of Shanghai University, who […] […]Read more "ADHS 2019"
Any of this stock market record due to Big Pharma boost from Jeff Sessions new memo against people's right to legal cannabis? https://t.co/HQotfSGzAl — Martha Densmore (@Acubody) January 4, 2018 Big Pharma wanted to sell more opioids. Then this happened..#opioidcrisis #opioid @conradhackett pic.twitter.com/rpHxGDeytW Alternatives, such as cannabis *cannot* overdose and are *way less* addictive — […]Read more "Big Pharma Round-Up V (#Cannabis edition)"
A lot happened in the world of pharmaceuticals this year. The opioid crisis worsened. The FDA got a new chief. There were big failures and prices reemerged as a major issue. Industry needed to contend with the new Trump administration and gene therapy ‘came of age.’ By the way, here is one year in review […]Read more "Big Pharma Round-Up III"